19491000087109: Canada English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\Canada English language reference set (foundation metadata concept)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 10-Aug 2009. Module: Canada Health Infoway English module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module

62731000087111 Canada English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

62741000087117 Canada English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) Canada Health Infoway English module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Canada English language reference set (foundation metadata concept)	est un(e) (attribut)	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
169-Hf	Acceptable (foundation metadata concept)
169-Yb	Acceptable (foundation metadata concept)
16G	Preferred (foundation metadata concept)
16G (qualifier value)	Preferred (foundation metadata concept)
16PF - Personality factor questionnaire	Acceptable (foundation metadata concept)
16p partial trisomy syndrome	Preferred (foundation metadata concept)
16p partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
16p11.2 deletion syndrome	Acceptable (foundation metadata concept)
16p11.2p12.2 microdeletion syndrome	Preferred (foundation metadata concept)
16p11.2p12.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
16p11.2p12.2 microduplication syndrome	Preferred (foundation metadata concept)
16p11.2p12.2 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
16p12.2 microdeletion	Acceptable (foundation metadata concept)
16p12.2 microdeletion syndrome	Preferred (foundation metadata concept)
16p12.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
16p13.11 microdeletion syndrome	Preferred (foundation metadata concept)
16p13.11 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
16p13.11 microduplication syndrome	Preferred (foundation metadata concept)
16p13.11 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
16p13.2 microdeletion syndrome	Preferred (foundation metadata concept)
16p13.2 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
16p13.3 microduplication syndrome	Preferred (foundation metadata concept)
16p13.3 microduplication syndrome (disorder)	Preferred (foundation metadata concept)
16q partial monosomy syndrome	Preferred (foundation metadata concept)
16q partial monosomy syndrome (disorder)	Preferred (foundation metadata concept)
16q partial trisomy syndrome	Preferred (foundation metadata concept)
16q partial trisomy syndrome (disorder)	Preferred (foundation metadata concept)
16q24.1 microdeletion syndrome	Preferred (foundation metadata concept)
16q24.1 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
16q24.3 microdeletion syndrome	Preferred (foundation metadata concept)
16q24.3 microdeletion syndrome (disorder)	Preferred (foundation metadata concept)
16x/day	Acceptable (foundation metadata concept)
17	Acceptable (foundation metadata concept)
17	Preferred (foundation metadata concept)
17 (qualifier value)	Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement	Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement (procedure)	Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, amniotic fluid	Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, amniotic fluid (procedure)	Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, serum	Preferred (foundation metadata concept)
17 Hydroxyprogesterone measurement, serum (procedure)	Preferred (foundation metadata concept)
17 OHP - 17-hydroxyprogesterone	Acceptable (foundation metadata concept)
17 alpha-Hydroxylase deficiency	Acceptable (foundation metadata concept)
17 alpha-Hydroxyprogesterone aldolase deficiency	Preferred (foundation metadata concept)
17 alpha-Hydroxyprogesterone aldolase deficiency (disorder)	Preferred (foundation metadata concept)
17 alpha-hydroxyprogesterone	Preferred (foundation metadata concept)
17 alpha-hydroxyprogesterone	Acceptable (foundation metadata concept)
17 alpha-hydroxyprogesterone (substance)	Preferred (foundation metadata concept)
17 beta-estradiol	Preferred (foundation metadata concept)
17 beta-estradiol (substance)	Preferred (foundation metadata concept)
17 beta-estradiol preparation	Preferred (foundation metadata concept)
17 beta-estradiol preparation (product)	Preferred (foundation metadata concept)
17 beta-hydroxysteroid dehydrogenase	Acceptable (foundation metadata concept)
17,18,21-trihydroxypregn-4-ene-3,11,20-trione	Acceptable (foundation metadata concept)
17,21-dihydroxypregnenolone	Preferred (foundation metadata concept)
17,21-dihydroxypregnenolone (substance)	Preferred (foundation metadata concept)
17,21-hydroxyprogesterone	Acceptable (foundation metadata concept)
17-Beta-estriol	Preferred (foundation metadata concept)
17-Beta-estriol (substance)	Preferred (foundation metadata concept)
17-Hydroxycorticosteroid	Preferred (foundation metadata concept)
17-Hydroxycorticosteroid (substance)	Preferred (foundation metadata concept)
17-Hydroxyketosteroids measurement	Preferred (foundation metadata concept)
17-Hydroxyketosteroids measurement (procedure)	Preferred (foundation metadata concept)
17-Hydroxypregnenolone measurement	Preferred (foundation metadata concept)
17-Hydroxypregnenolone measurement (procedure)	Preferred (foundation metadata concept)
17-KGS measurement	Acceptable (foundation metadata concept)
17-KS measurement	Acceptable (foundation metadata concept)
17-KS measurement, fractionation	Acceptable (foundation metadata concept)
17-KSR deficiency	Acceptable (foundation metadata concept)
17-Ketogenic steroid	Preferred (foundation metadata concept)
17-Ketogenic steroid (substance)	Preferred (foundation metadata concept)
17-Ketogenic steroids measurement	Preferred (foundation metadata concept)
17-Ketogenic steroids measurement (procedure)	Preferred (foundation metadata concept)
17-Ketosteroid reductase deficiency	Acceptable (foundation metadata concept)
17-Ketosteroids	Acceptable (foundation metadata concept)
17-Ketosteroids measurement	Preferred (foundation metadata concept)
17-Ketosteroids measurement (procedure)	Preferred (foundation metadata concept)
17-Ketosteroids measurement, fractionation, urine	Preferred (foundation metadata concept)
17-Ketosteroids measurement, fractionation, urine (procedure)	Preferred (foundation metadata concept)
17-Ketosteroids measurement, total	Preferred (foundation metadata concept)
17-Ketosteroids measurement, total (procedure)	Preferred (foundation metadata concept)
17-O-deacetylvindoline O-acetyltransferase	Preferred (foundation metadata concept)
17-O-deacetylvindoline O-acetyltransferase (substance)	Preferred (foundation metadata concept)
17-OHCS measurement	Acceptable (foundation metadata concept)
17-Oxogenic steroid	Acceptable (foundation metadata concept)
17-Oxosteroid	Preferred (foundation metadata concept)
17-Oxosteroid (substance)	Preferred (foundation metadata concept)
17-alpha-18,21-trihydroxypregn-4-ene-3,20-dione	Acceptable (foundation metadata concept)
17-alpha-hydroxypregnenolone	Acceptable (foundation metadata concept)
17-beta estradiol	Acceptable (foundation metadata concept)
17-hydrocorticosteroid	Acceptable (foundation metadata concept)
17-hydroxycorticoid	Acceptable (foundation metadata concept)
17-hydroxycorticosteroid	Preferred (foundation metadata concept)
17-hydroxycorticosteroid (substance)	Preferred (foundation metadata concept)
17-hydroxycorticosteroid measurement	Preferred (foundation metadata concept)
17-hydroxycorticosteroid measurement (procedure)	Preferred (foundation metadata concept)
17-hydroxylase	Acceptable (foundation metadata concept)
17-hydroxypregnenolone	Preferred (foundation metadata concept)
17-hydroxypregnenolone (substance)	Preferred (foundation metadata concept)
17-hydroxyprogesterone	Preferred (foundation metadata concept)
17-hydroxyprogesterone (substance)	Preferred (foundation metadata concept)

Start Previous Page 73 of 12575 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
62731000087111	Canada English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)
62741000087117	Canada English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	Canada Health Infoway English module (core metadata concept)